Cytomegalovirus (CMV) vaccine in donors and recipients undergoing allogeneic hematopoietic cell transplant (HCT)

Trial Identifier: CB01-202
Sponsor: Astellas Pharma Inc.
Collaborator:
Vical
Start Date: January 2006
Primary Completion Date: November 2009
Study Completion Date: November 2010
Condition: Leukemia; Heart, Blood & Circulatory - Other; Non-Hodgkin's Lymphoma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Arizona Tucson, Arizona, United States, 85724
United States, Colorado Denver, Colorado, United States, 80218
United States, Florida Tampa, Florida, United States, 33612
United States, Illinois Chicago, Illinois, United States, 60637
United States, Kansas Westwood, Kansas, United States, 66205
United States, KY Louisville, KY, United States, 40202
United States, Massachusetts Boston, Massachusetts, United States, 02115
United States, Michigan Detroit, Michigan, United States, 48201
United States, Minnesota Rochester, Minnesota, United States, 55905
United States, NC Winston-Salem, NC, United States, 27157
United States, Nebraska Omaha, Nebraska, United States, 68198
United States, New York Buffalo, New York, United States, 14263
United States, New York Rochester, New York, United States, 14642
United States, NJ Hackensack, NJ, United States, 07601
United States, Texas Dallas, Texas, United States, 75390
United States, Washington Seattle, Washington, United States, 98109-1024
USA, CA Duarte, CA, USA, 91010
USA, GA Atlanta, GA, USA, 30322
USA, IL Chicago, IL, USA, 60612
USA, New York Bronx, New York, USA, 10467
USA, New York New York, USA, 10021
USA, Texas Dallas, Texas, USA, 75246